149 related articles for article (PubMed ID: 31556252)
1. Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross-infections.
Milczewska J; Wołkowicz T; Zacharczuk K; Mierzejewska E; Kwiatkowska M; Walicka-Serzysko K; Sands D
Pediatr Pulmonol; 2020 Jan; 55(1):161-168. PubMed ID: 31556252
[TBL] [Abstract][Full Text] [Related]
2. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.
Denton M; Kerr K; Mooney L; Keer V; Rajgopal A; Brownlee K; Arundel P; Conway S
Pediatr Pulmonol; 2002 Oct; 34(4):257-61. PubMed ID: 12205566
[TBL] [Abstract][Full Text] [Related]
3. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R; Champion A; Reid DW
Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
[TBL] [Abstract][Full Text] [Related]
4. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
Milczewska J; Wołkowicz T; Zacharczuk K; Kwiatkowska M
Dev Period Med; 2015; 19(1):60-5. PubMed ID: 26003071
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa infection among cystic fibrosis and ICU patients in the referral children medical hospital in Tehran, Iran.
Movahedi Z; Pourakbari B; Mahmoudi S; Sabouni F; Ashtiani Haghi MT; Hosseinpour Sadeghi R; Mamishi S
J Prev Med Hyg; 2013 Mar; 54(1):24-8. PubMed ID: 24397002
[TBL] [Abstract][Full Text] [Related]
6. Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa.
Jones AM; Dodd ME; Doherty CJ; Govan JR; Webb AK
Thorax; 2002 Nov; 57(11):924-5. PubMed ID: 12403871
[TBL] [Abstract][Full Text] [Related]
7. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic & genotypic variants of Pseudomonas aeruginosa isolated from children with cystic fibrosis in India.
Agarwal G; Kapil A; Kabra SK; Chandra R; Das B; Diwedi SN
Indian J Med Res; 2002 Aug; 116():73-81. PubMed ID: 12592994
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
10. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
[TBL] [Abstract][Full Text] [Related]
11. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
[TBL] [Abstract][Full Text] [Related]
12. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units.
O'Carroll MR; Syrmis MW; Wainwright CE; Greer RM; Mitchell P; Coulter C; Sloots TP; Nissen MD; Bell SC
Eur Respir J; 2004 Jul; 24(1):101-6. PubMed ID: 15293611
[TBL] [Abstract][Full Text] [Related]
13. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome for cystic fibrosis patients infected with transmissible pseudomonas aeruginosa: an 8-year prospective study.
Jones AM; Dodd ME; Morris J; Doherty C; Govan JR; Webb AK
Chest; 2010 Jun; 137(6):1405-9. PubMed ID: 20081099
[TBL] [Abstract][Full Text] [Related]
15. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients.
Fluge G; Ojeniyi B; Høiby N; Digranes A; Ciofu O; Hunstad E; Haanaes OC; Storrøsten OT
Clin Microbiol Infect; 2001 May; 7(5):238-43. PubMed ID: 11422250
[TBL] [Abstract][Full Text] [Related]
16. Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.
Valenza G; Radike K; Schoen C; Horn S; Oesterlein A; Frosch M; Abele-Horn M; Hebestreit H
Scand J Infect Dis; 2010 Dec; 42(11-12):885-9. PubMed ID: 20735333
[TBL] [Abstract][Full Text] [Related]
17. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
[TBL] [Abstract][Full Text] [Related]
18. Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.
Conway SP; Pond MN; Watson A; Etherington C; Robey HL; Goldman MH
Thorax; 1997 Nov; 52(11):987-93. PubMed ID: 9487348
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa.
Lechtzin N; John M; Irizarry R; Merlo C; Diette GB; Boyle MP
Respiration; 2006; 73(1):27-33. PubMed ID: 16113513
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
